Content uploaded by Henry Daniell
Author content
All content in this area was uploaded by Henry Daniell on Apr 02, 2015
Content may be subject to copyright.
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 31
Biotechnol. J. 2006, 1, 26–33 www.biotechnology-journal.com
The Daniell laboratory has pioneered and advanced the
concept of chloroplast genetic engineering. Plant genetic
engineering research was revolutionized with the accu-
mulation of Bacillus thuringiensis (Bt) cry2Aa2 protein at
46.1% in transgenic chloroplasts [1]. It was not only the
highest accumulation of protein in transgenic plants but
a complete bacterial operon was successfully expressed,
for the first time, resulting in the formation of stable
cry2Aa2 crystals. Transgenes express large amounts of
foreign protein due to the high copy number of the chloro-
plast genome in each plant cell—up to 10,000 copies of
transgene per cell [2–8]. Transgenes are integrated into
the spacer regions of the chloroplast genome by homolo-
gous recombination of flanking sequences. This allows
site-specific integration and eliminates concerns of posi-
tion effect, frequently observed in nuclear transgenic
plants. As a result, it is not necessary to screen large num-
bers of putative transgenic lines to choose for high-level
expression of transgenes. In contrast, all chloroplast trans-
genic lines express similar levels of foreign proteins, with-
in the range of physiological variations [9]. In addition,
site-specific integration by homologous recombination
eliminates introduction of vector sequences, which is
often a concern in nuclear transformation achieved by
non-homologous recombination. Yet another advantage
is the lack of transgene silencing in chloroplast transgenic
plants, which is a serious concern in nuclear transforma-
tion. There is no gene silencing in chloroplast transgenic
lines at the transcriptional levels despite accumulation of
transcripts 169-fold higher than nuclear transgenic plants
[10, 11]. Similarly, there is no post-transcriptional gene
silencing despite accumulation of foreign proteins up to
47% of the total plant protein in cp transgenic lines [1].
In most angiosperms, plastids are maternally inherit-
ed, which minimizes the concern of outcrossing of trans-
genes [12, 13] and reduces the potential toxicity of trans-
genic pollen to non-target insects [1]. Maternal inheri-
tance of transgenes offers containment because of lack of
gene flow through pollen [13] and this has been demon-
strated in different plant species [7, 12, 14]. The Daniell
laboratory developed a chloroplast genome derived cyto-
plasmic male sterility system in which the tapetal layers
are destroyed in developing pollen, making transgenic
plants male sterile without affecting other metabolic func-
tions [15]. This provides yet another strategy for trans-
gene containment. Chloroplast transgenic carrot plants
have been engineered to withstand salt concentrations
only halophytes could tolerate [16]. The Daniell laboratory
has conferred several other plant traits, including herbi-
cide [12], insect [17], and disease [18] resistance, drought
[10], phytoremediation [19] and production of biopolymers
[20].
The chloroplast is an ideal cellular location to express
and accumulate certain proteins or their biosynthetic
products that would otherwise be harmful to the plant if
they were expressed in the cytoplasm. This has been
demonstrated by the non-toxic effect of cholera toxin B
subunit (CTB), a candidate oral subunit vaccine for
cholera, when it was accumulated in large quantities
within transgenic plastids; in contrast, even very small
quantities of CTB were toxic when expressed in the cyto-
plasm [9, 21]. Also, trehalose, which is a pharmaceutical
preservative, was very toxic when it was accumulated in
the cytosol but was non-toxic when it was compartmen-
talized within plastids [10].
Oral delivery of vaccine antigens has been shown to
yield high systemic IgG titers and high mucosal IgA
titers, enabling the immune system to fight germs at their
portals of entry. Therefore, the Daniell laboratory has
demonstrated expression and assembly of several vac-
cine antigens, including the cholera toxin B subunit (CTB)
[9], the F1~V fusion antigen for plague [6]; the 2L21 pep-
tide from the canine parvovirus (CPV) [21], the anthrax
protective antigen (PA) [22], and the NS3 protein as a vac-
cine antigen for hepatitis C [6]. Cytotoxicity measure-
Henry Daniell: Chloroplast genetic engineering
Henry Daniell is Pegasus Professor and
Trustee Chair at the University of Cen-
tral Florida (UCF). He is an elected
member of the Italian Academy of Sci-
ences. Daniell is the technical founder
of Chlorogen, Inc. (which received mul-
ti-million dollar investment) and an
inventor on more than 95 patents
(awarded or in prosecution) in the US
and abroad. Daniell has served as a
consultant to the United Nations on biotechnology for many years and
to major biotechnology companies and appears often on television
shows or newspaper articles around the world. Prof. Daniell also
served on numerous panels on Biodefense and Bioterrorism Risk
Assessment. Daniell is recognized for his pioneering inventions on
chloroplast genetic engineering. He developed and advanced this con-
cept, which overcomes concerns of transgene containment. He used
this concept to confer plant traits, including herbicide, insect, disease
resistance, drought/salt tolerance or phytoremediation. Furthermore,
this concept has been used in his laboratory to express several thera-
peutic proteins, including vaccine antigens and biopharmaceuticals.
Daniell has published over 150 articles in premier scientific journals
(cited over 1500 times).
026_BIOT_SeniorEditors.qxd 22.12.2005 7:34 Uhr Seite 31
Biotechnology
Journal
Biotechnol. J. 2006, 1, 26–33
32 © 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ments in macrophage lysis assays showed that chloro-
plast-derived anthrax protective antigen (PA) was equal
in potency to PA produced in B. anthracis. Subcutaneous
immunization of mice with partially purified chloroplast-
derived or B. anthracis-derived PA with adjuvant both
yielded IgG titers up to 1:320 000, and both groups of mice
survived (100%) challenge with lethal doses of toxin. It
was reported that an average yield of about 150 mg of PA
per plant should produce 360 million doses of a purified
vaccine free of the bacterial toxins EF and LF, from one
acre of land [23]. However, these examples only demon-
strate the use of single vaccine antigens derived from
chloroplasts. Recent transcript analyses conducted on
chloroplast transgenic lines showed that the engineered
multigenic operons were transcribed mostly as poly-
cistrons and were efficiently translated, demonstrating
that transcripts need not be monocistronic to be translat-
ed [24], thus facilitating the development of multivalent
vaccines.
In addition to its use for the hyper-expression of vac-
cine antigens, the tobacco chloroplast has been used in
the Daniell laboratory for production of valuable therapeu-
tic proteins, such as human elastin-derived polymers for
various biomedical applications [25], human serum albu-
min [26], magainin, a broad spectrum topical agent, sys-
temic antibiotic, wound healing stimulant and a potential
anticancer agent [18], interferon and insulin-like growth
factor [3, 6]. These examples show that chloroplast also
contains the machinery that allows for correct folding and
disulfide bond formation, resulting in fully functional pro-
teins. Finally, the transformation of non-green tissue plas-
tids like cotton [14] and carrot [16] were recently achieved
[6], further facilitating oral delivery of therapeutic pro-
teins. To advance the concept of oral delivery of thera-
peutic proteins, an antibiotic free cp transformation sys-
tem has been developed [27]. In order to advance chloro-
plast genetic engineering to other crops, ten new crop
chloroplast genomes have been sequenced recently,
including soybean [28].
References
[1] DeCosa, B., Moar, W., Lee, S.B., Miller, M., Daniell, H., Overexpres-
sion of the Bt Cry2Aa2 operon in chloroplasts leads to formation of
insecticidal crystals. Nat. Biotechnol. 2001, 19, 71–74
[2] Daniell, H, Molecular strategies for gene containment in transgenic
crops. Nat. Biotechnol. 2002, 20, 581–587.
[3] Daniell, H., Carmona-Sanchez, O., Burns, B., Chloroplast derived
antibodies, biopharmaceuticals and edible vaccines. In: Schillberg,
S. (Ed.), Mol. Farming, Wiley–VCH Verlag, Germany 2004, Chapter
8, pp 113–133.
[4] Daniell, H., Cohill, P. R., Kumar, S., Dufourmantel, N., Chloroplast
genetic engineering. In: Daniell, H. and Chase, C.D. (Eds.), Molecu-
lar Biology and Biotechnology of Plant Organelles, Springer, the
Netherlands 2004, pp 437–484.
[5] Daniell, H., Dhingra, A., Ruiz, O.N. Chloroplast genetic engineering
to confer desired plant traits. Methods Mol. Biol. 2004, 286, 111–137
[6] Daniell, H., Chebolu, S., Kumar, S., Singleton, M., Falconer, R.,
Chloroplast- derived Vaccine antigens and other Therapeutic pro-
teins. Vaccine 2005, 23, 1779–1783.
[7] Daniell, H., Kumar, S., Duformantel, N., Breakthrough in chloroplast
genetic engineering of agronomically important crops. Trends
Biotechnol. 2005, 23, 238–245.
[8] Grevich, J., Daniell, H., Chloroplast genetic engineering: Recent
advances and perspectives. Crit. Rev. Plant Sci. 2005, 24, 1–25.
[9] Daniell, H., Lee, S.B., Panchal, T., Wiebe, P.O., Expression of the
native cholera toxin B subunit gene and assembly as functional
oligomers in transgenic tobacco chloroplasts. J. Mol. Biol. 2001, 311,
1001–1009.
[10] Lee, S.B., Byun, M.O., Daniell, H., Accumulation of trehalose within
transgenic chloroplasts confers drought tolerance. Mol. Breed. 2003,
11, 1–13.
[11] Dhingra, A., Portis, A.R., Daniell, H., Enhanced translation of a
chloroplast expressed RbcS gene restores SSU levels and photosyn-
thesis in nuclear antisense RbcS plants. Proc. Natl. Acad. Sci. U.S.A.
2004, 101, 6315–6320.
[12] Daniell, H., Datta, R., Varma, S., Gray, S., Lee, S.B., Containment of
herbicide resistance through genetic engineering of the chloroplast
genome. Nat. Biotechnol. 1998, 16, 345¯348.
[13] Daniell, H., Khan, M.S. Allison, L., Milestones in chloroplast genetic
engineering: an environmentally friendly era in biotechnology.
Trends Plant Sci. 2002, 7, 84–91.
[14] Kumar, S., Dhingra, A., Daniell, H., Manipulation of gene expression
facilitates cotton plastid transformation of cotton by somatic
embryogenesis & maternal inheritance of transgenes. Plant Mol.
Biol. 2004, 56, 203–216.
[15] Ruiz, O. N., Daniell, H., Engineering cytoplasmic male sterility via
the chloroplast genome. Plant Physiol. 2005, 138, 1232–1246, fea-
tured on the cover and in Nature as a News & Views article.
[16] Kumar, S., Dhingra, A., Daniell, H., Plastid expressed betaine alde-
hyde dehydrogenase gene in carrot cultured cells, roots and leaves
confers enhanced salt tolerance. Plant Physiol. 2004, 136, 2343–2354.
[17] Kota, M., Daniell, H., Varma, S., Garczynski, S.F., Gould F., William,
M.J., Overexpression of the Bacillus thuringiensis (Bt) Cry2Aa2 pro-
tein in chloroplasts confers resistance to plants against susceptible
and Bt-resistant insects. Proc. Natl. Acad. Sci. U.S.A. 1999, 96,
1840¯1845.
[18] DeGray, G., Kanniah, R., Franzine, S., John, S., and Daniell H.,
Expression of an antimicrobial peptide via the chloroplast genome
to control phytopathogenic bacteria and fungi. Plant Physiol. 2001,
127, 852¯862.
[19] Ruiz, O.N., Hussein, H., Terry N., Daniell, H., Phytoremediation of
organomercurial compounds via chloroplast genetic engineering.
Plant Physiol. 2003, 132, 1344–1352.
[20] Vitanen, P.V., Devine, A. L., Kahn, S., Deuel, D. L., Van Dyk, D. E.,
Daniell, H., Metabolic engineering of the chloroplast genome using
the E. coli ubiC gene reveals that corismate is a readily abundant
precursor for 4-hydroxybenzoic acid synthesis in plants. Plant Phys-
iol. 2004, 136, 4048–4060.
[21] Molina, A., Daniell, H., Mingo-Castel, A., Veramendi, J., High-yield
expression of a viral peptide animal vaccine in transgenic tobacco
chloroplasts. Plant Biotechnol. J. 2004, 2, 141–153.
[22] Watson, J., Koya, V., Leppla, S., Daniell, H., Expression of Bacillus
anthracis protective antigen in transgenic chloroplasts of tobacco, a
non-food/feed crop. Vaccine 2004, 22, 4374–4384.
[23] Koya, V., Moayeri, M., Leppla, S.H., Daniell, H., Plant based vaccine:
mice immunized with chloroplast-derived anthrax protective anti-
gen survive anthrax lethal toxin challenge. Infect. Immun. 2005, 73,
1–9.
© 2006 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim 33
Biotechnol. J. 2006, 1, 26–33 www.biotechnology-journal.com
[24] Quesada-Vargas, T., Ruiz, O.N., Daniell, H., Characterization of het-
erologous multigene operons in transgenic chloroplasts: transcrip-
tion, processing and translation. Plant Physiol. 2005, 138, 1746–1762.
[25] Guda, C., Lee, S.B., Daniell, H., Stable expression of biodegradable
protein based polymer in tobacco chloroplasts. Plant Cell Rep. 2000,
19, 257¯262.
[26] Fernandez-San, M., Mingeo-Castel, A., Miller M., and Daniell H., A
chloroplast transgenic approach to hyper-express and purify Human
Serum Albumin, a protein highly susceptible to proteolytic degra-
dation. Plant Biotechnol. J. 2003, 1, 71–79.
[27] Daniell, H., Muthukumar, B., Lee, S.B., Marker tree transgenic
plants: engineering the chloroplast genome without the use of
antibiotic selection. Curr. Genet. 2001, 39, 109–116.
[28] Saski, C., Lee, S.B., Daniell, H. Tomkins, J., Kim, H.G. Jansen, R.K.,
Complete chloroplast genome sequence of Glycine max and com-
parative analysis with other legumes. Plant Mol. Biol. 2005, in press.
Note:
Our Senior Editors Pushpa M. Bhargava, Theo Dinger-
mann, Marc Blondel and Zhuan Cao are introduced with
their original articles hereafter. The remaining Senior Edi-
tors will be introduced in a coming issue of Biotechnolo-
gy Journal.